Fig. 4From: Patient-reported experience with Fabry disease and its management in the real-world setting: results from a double-blind, cross-sectional survey of 280 respondentsBurden of ERT: Infusion duration reported by respondents currently or previously receiving ERT (N = 240). ERT, enzyme replacement therapyBack to article page